baber/WOPTO huggingface dataset:
Patent CA-2721084-A1 (CA)
Inventor: GUYOT RAPHAEL EMMANUEL
IPC: C11D3/30
Filed: 2009-05-19
Abstract: Aqueous laundry detergent compositions useful for providing fabric cleaning and softness are described, in the form of a liquid or gel, having a pH of from 6 to 11 in a 1% solution containing a non-soap anionic surfactant; optional soap;  nonionic surfactant; optional hydrotrope; fabric softening cationic cosurfactant having a molecular weight of less than 1000; fabric softening quaternized polymer having a molecular weight of at least 200,000;  perfume deposition polyamine wherein the perfume deposition polyamine has a molecular weight of from 5,000 to 50,000; a non-quaternized, non polyamine thickener; and perfume.  Methods of using such compositions and use of such compositions are described.
Patent CA-2722302-A1 (CA)
Inventor: BLIN GUILLAUME
IPC: H04B1/38
Filed: 2008-04-21
Abstract: Un mode de réalisation de la présente invention propose un appareil, comprenant un réseau d'adaptation RF connecté à au moins un port d'entrée RF et à au moins un port de sortie RF et comprenant un ou plusieurs éléments réactifs variables commandés en tension ou en courant; et dans lequel le réseau d'adaptation RF est réglé pour optimiser le réseau d'adaptation RF et dans lequel ledit réglage est limité par un nombre prédéterminé de pas de réglage qui sont pris à l'intérieur d'une salve de transmission et/ou limité par l'amplitude de chaque pas pris à l'intérieur d'une salve de transmission et/ou limité aux pas uniquement permis entre les salves.
Patent CA-2723559-A1 (CA)
Inventor: VON NUSSBAUM FRANZ
IPC: A61K31/519
Filed: 2009-04-24
Abstract: The present invention relates to new 1,4-diaryl-pyrimido[4,5-d]pyridazine-2,5-dione derivatives, to processes for preparing them, to their use, alone or in combinations, for treating and/or preventing diseases, and to their use for preparing pharmaceuticals for the treatment and/or prevention of diseases, more particularly for the treatment and/or prevention of diseases of the lungs and of the cardiovascular system.
Patent CA-2723864-A1 (CA)
Inventor: LANE MICHAEL T
IPC: B65D1/42
Filed: 2009-05-13
Abstract: A one-piece plastic container includes a container body and an upper portion having a finish. Integrally formed with the finish and extending downward therefrom is a shoulder region. The shoulder region merges into and provides a transition between the finish and a sidewall portion. The sidewall portion extends downward from the shoulder region to a base portion having a base. The sidewall portion defines a series of horizontal lands and horizontal ribs. The horizontal lands and horizontal ribs extend continuously in a vertical direction from the shoulder region to the base portion. The horizontal ribs are designed to achieve optimal performance with regard to vacuum absorption, top load strength capabilities and dent resistance.
Patent CA-2724090-A1 (CA)
Inventor: WINTER BRUCE EDWARD
IPC: H04M1/724
Filed: 2010-12-07
Abstract: A wireless device and method are provided for redialling of conference calls comprising: establishing a call connection based on a first dialled number;  monitoring for subsequent numbers dialled after the establishment of the call connection; determining if the subsequent numbers dialled meet predetermined criteria; and saving the first dialled number and the subsequent numbers dialled in a memory of the wireless device as a saved first dialled number and saved subsequent numbers if the predetermined criteria are met.
Patent CA-2724257-A1 (CA)
Title: Antibodies to il-6 and their uses
Inventor: RAJPAL ARVIND
IPC: A61K39/395
Filed: 2009-06-10
Abstract: Antibodies and antigen-binding portions thereof that bind to human IL-6 are provided. Also provided are nucleic acids encoding such antibodies and antigen binding portions, methods of making such antibodies and antigen binding portions, compositions comprising such antibodies or antigen binding portions, and uses of such antibodies or antigen binding portions.
Patent CA-2727729-A1 (CA)
Inventor: ROCK KELLY P
IPC: A61M11/06
Filed: 1999-03-11
Abstract: This disclosure relates to a centrifugal vortex system for preparing a liquid, such as fuel and includes a chamber housing defining a vortex chamber. An array of tangential apertures are formed in the chamber housing to permit fluid to be turbulently introduced into the vortex chamber to create a vortical flow of fluid through the vortex chamber. In one embodiment, a plurality of vortex chambers are arranged in series to allow the fluid to pass through several vortex chambers. In other embodiments, the chamber housing may be stepped, textured, or both to increase the turbulence of the flow through the chamber. In yet another embodiment, a pressure differential supply jacket is provided to normalize the amount of flow through the tangential apertures according to the location of the apertures. A centrifuge chamber is also disclosed which has a plurality of output conduits on a bottom surface and a tapered extension member downwardly extending from a top surface to enhance the centrifugal flow of the fluid. Additionally, a bypass conduit is provided to selectively permit the flow to bypass one or more chambers.
Patent CA-2729504-A1 (CA)
Inventor: CHIANG YET-MING
IPC: H01M8/04
Filed: 2001-10-22
Abstract: The effective ionic conductivity in a composite structure is believed to decrease rapidly with volume fraction. A system, such as a bipolar device or energy storage device, has structures or components in which the diffusion length or path that electrodes or ions must traverse is minimized and the interfacial area exposed to the ions or electrons is maximized. The device includes components that can be reticulated or has a reticulated interface so that an interface area can be increased. The increased interfacial perimeter increases the available sites for reaction of ionic species. Many different reticulation patterns can be used. The aspect ratio of the reticulated features can be varied. Such bipolar devices can be fabricated by a variety of methods or procedures. A  bipolar device having structures of reticulated interface can be tailored for the purposes of controlling and optimizing charge and discharge kinetics. A bipolar device having graded porosity structures can have improved transport properties because the diffusion controlling reaction kinetics can be modified. Graded porosity electrodes can be linearly or nonlinearly graded. A bipolar device having perforated structures also provides improved transport properties by removing tortuosity and reducing diffusion distance.
Patent CA-2733891-A1 (CA)
Title: Method, system and apparatus for multiplexing ions in msn mass spectrometry analysis
Inventor: LOBODA ALEXANDRE
IPC: H01J49/10
Filed: 2009-09-29
Abstract: A method and apparatus for multiplexing ions in an MSn mass spectrometer is provided. Ion are filtered to produce a group of ions of interest, the group of ions below a space charge limit of the MSn mass spectrometer. At least a portion of the group of ions are fragmented to form a fragmented group of ions.  At least a portion of the fragmented group are stored such that a plurality of portions of the fragmented group can be sequentially selected for mass spectrometry analysis. Each of the plurality of portions of the fragmented group are sequentially selected and refragmented prior to mass spectrometry analysis. Each of the plurality of portions of the fragmented group are analyzed, via mass spectrometry, once each of the plurality of portions of the fragmented group has been fragmented.
Patent CA-2734814-A1 (CA)
Inventor: WIGERINCK PIET TOM BERT PAUL
IPC: C07D493/04
Filed: 2009-09-01
Abstract: The present invention relates to a process for the preparation of (3R,3a S,6aR)-hexa-hydrofuro [2,3-b] furan-3-yl (1S,2R)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate as well as novel intermediates for use in said process. (3R,3a S,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate is particularly useful as an HIV protease inhibitor.
Patent CA-2735940-A1 (CA)
Inventor: SCANNON PATRICK J
IPC: A61K39/395
Filed: 2009-09-04
Abstract: Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, decreased insulin production, hyperglycemia, hypoinsulinemia, metabolic syn-drome, Type 1 diabetes and obesity, comprising administering to a subject an effective amount of anti-IL-1 antibody or fragment thereof.
Patent CA-2736641-A1 (CA)
Inventor: GRAHAM MICHAEL E
IPC: B23K35/30
Filed: 2002-11-21
Abstract: A brazing product for fluxless brazing comprises an aluminum or aluminum alloy substrate; a layer of an aluminum eutectic-forming layer applied to the substrate, and a braze-promoting layer comprising one or more metals from the group comprising nickel, cobalt and iron is applied on the eutectic-forming layer. The eutectic-forming layer is preferably Si deposited by physical vapor deposition. The brazing product may be brazed to another aluminum shape or to a shape comprised of a dissimilar metal.
Patent CA-2739844-A1 (CA)
Title: Procede et dispositif de surveillance et/ou d'analyse de rotors de machines electriques en fonctionnement
Inventor: HOBELSBERGER MAX
IPC: H02P29/00
Filed: 2009-10-13
Abstract: L'invention concerne un procédé de surveillance et/ou d'analyse de machines électriques en fonctionnement, une machine électrique comportant au moins un générateur doté d'un arbre, un système d'excitation et des moyens d'entraînement pour entraîner cet arbre. Selon l'invention, un premier signal décrivant une tension de l'enroulement de rotor et un deuxième signal décrivant un courant traversant l'enroulement de rotor sont mesurés simultanément. Les deux signaux sont envoyés à une unité d'analyse dans laquelle les signaux sont subdivisés en composants de fréquence individuels. Ensuite, l'impédance de l'enroulement de rotor est déterminée pour détecter des états de dysfonctionnement dans la machine électrique.
Patent CA-2740530-A1 (CA)
Inventor: LIANG YONGLIN
IPC: A61K31/197
Filed: 2009-07-06
Abstract: Alexipharmic cigarette filter material and its produce means are disclosed. The filter material is organic material in the tea which comprises Y-propalanine, theanine, glutamic acid, tryptophan and tea alkaloid. Some fibrin is added to produce tea powder, tea flake and tea grain. The cigarette tip, the cigarette filter stick and the cigarette holder core part are produced via the tea powder, tea flake, tea grain, active material and the additive in a kind of vertically produced way.
Patent CA-2746592-A1 (CA)
Inventor: LINDSEY JOE T
IPC: A47L5/36
Filed: 2011-07-15
Abstract: The present invention relates to an electrical connector assembly including a male connector having a first plug body and a first electrical prong and a cooperating female connector having a second plug body with a cavity, a first electrical contact held in that cavity and a resilient shield received in the cavity. The resilient shield is displaceable from a first position covering the electrical contact and preventing intrusion of dirt and debris into the contact to a second position exposing the electrical contact for connection with the electrical prong.
Patent CA-2747035-A1 (CA)
Inventor: FISCHER RUDIGER
IPC: A01N43/713
Filed: 2009-12-09
Abstract: L'invention concerne des amides d'acide anthranilique substitués par tétrazol de formule (I), dans laquelle R1, R2. R3. R4, R5, n, X et Q ont les significations mentionnées dans la description. L'invention concerne également leur utilisation comme insecticides et/ou acaricides y compris en combinaison avec d'autres agents tels que des activateurs de pénétration et/ou des sels d'ammonium ou de phosphonium.
Patent CA-2747565-A1 (CA)
Inventor: COLLINS JONATHAN
IPC: A61P35/00
Filed: 2009-12-17
Abstract: The present application relates to novel C-1 substituted analogues of pancratistatin and 7-dexoypancratistatin of Formula (I), pharmaceutical compositions thereof and the use of said compounds of Formula (I) in the treatment of cancer The application also relates to processes for the preparation of said compound of Formula (I) and intermediates thereof.
Patent CA-2748563-A1 (CA)
Title: Biometric key
Inventor: BACCHIAZ JOHN DAVID
IPC: G06F21/00
Filed: 2011-08-03
Abstract: A biometric key (10) which has an interface or electrical connection to a receptor body (11) which functions as an external power source a biometric sensor, a CPU, a nonvolatile memory unit incorporating a database of authorised biometric signatures or biocodes along with associated firmware required for comparison between data received from the biometric sensor and to provide acceptance or rejection of said data upon electrical connection to the receptor body (11) whereby a signal is sent to a facility (12, 13, 15, 16, 17) accessible by the key (10) advising of said acceptance or rejection.
Patent CA-2752510-A1 (CA)
Inventor: BANDER NEIL
IPC: A61K51/10
Filed: 2010-02-17
Abstract: A method for identifying a patient for cancer therapy can include administering a diagnostic dose of a detectably labeled first binding agent to a patient, the detectably labeled binding agent being capable of binding a molecular target. The method also includes selecting a patient for administration of a therapeutic dose of a second binding agent capable of binding a cellular target, wherein the selected patient exhibits a positive reading for the detectably labeled first binding agent. Furthermore, the method can include administering a therapeutic dose of the second binding agent to the patient.
Patent CA-2752892-A1 (CA)
Inventor: TIEDTKE HANS-JUERGEN
IPC: A61B17/34
Filed: 2009-03-10
Abstract: The present invention provides a plug device or grommet (1) for sealing an incision in tissue of a human or animal body, such as an incision in the tissue of the sclera (S) made during a surgical intervention for the implantation of a visual prosthesis.  The device (1) comprises: a cover part (10) for covering the incision and an area of the tissue (S) around the incision; and an insertion part (20) extending from the cover part (10) for insertion into the incision through the tissue (S). The insertion part (20) defines a sealable passage (30) which is adapted to extend through the incision, and the insertion part (20) is preferably flexible and resiliency deformable to open and close the sealable passage (30) there-through. The sealable passage (30) extends through the incision to provide communication between an outer side (S0) of the tissue and an inner side (S i) of the tissue. The passage (30) may accommodate a component which provides a connection or interconnection through the tissue (S).
Patent CA-2753796-A1 (CA)
Inventor: DE MILLIANO MAARTEN JOHAN KULILELA
IPC: C12N15/82
Filed: 2010-03-01
Abstract: The present invention relates to a plant of a cucumber breeding line comprising an introgression from cucumber inbred line URS 189, a representative sample of seed of which has been deposited with the NCIMB, Aberdeen, Scotland under accession number NCIMB 41612 and depositors reference URS 189, or a Fusarium-resistant offspring plant of line URS 189, wherein said introgression confers to said plant of said cucumber breeding line resistance to the causal agent of Fusarium stem and root rot Fusarium oxysporum f.sp. radicis cucumerinum (Forc).
Patent CA-2759685-A1 (CA)
Title: Apparatuses and methods for applying a cryogenic effect to tissue and cutting tissue
Inventor: KRIMSKY WILLIAM S
IPC: A61B17/3211
Filed: 2010-04-23
Abstract: The disclosure provides a surgical device adapted to administer cryogen to a target tissue. The device may be equipped with one or more blades and the device may be adapted to deliver cryogen to a tissue before, during and/or after contact-ing the tissue with the blade. According to some embodiments, the device may be adapted to heat and/or cool the blade(s).
Patent CA-2761520-A1 (CA)
Inventor: LISKE DURGA
IPC: B65D85/74
Filed: 2011-12-13
Abstract: A method of packaging a moldable food product includes providing a base tray having a plurality of compartments arranged in an array, wherein each of the compartments has an interior space defining a volume for storing the moldable food product, an open end, and inter-compartmental walls extending from the open end on at least two sides;  filling the compartments with the moldable food product, wherein the moldable food product is in a first phase; cooling the moldable food product in each of the compartments to increase a solidity of the moldable food product with respect to the first phase to allow the moldable food product to conform to the shape of the interior space of the compartment; and sealing the filled compartments so as to cover the open ends of the compartments.
Patent CA-2765035-A1 (CA)
Title: Porous material having controlled voids and method of making the same
Inventor: GAWRYLA MATTHEW D
IPC: B01J13/00
Filed: 2010-06-11
Abstract: A porous material having controlled void dimensions and method of forming the same includes forming an aerogel precursor, the aerogel precursor including a matrix material and a liquid dispersion medium for dispersing the matrix material. A plurality of particles having preselected dimensions is dispersed in the aerogel precursor. The aerogel precursor with the particles dispersed therein is frozen so that the liquid dispersion is solidified. The aerogel precursor is freeze dried to sublime the dispersion medium and form the porous material.
Patent CA-2765908-A1 (CA)
Title: Force monitor for pulverizer integral spring assembly
Inventor: STONE RICHARD BRIAN
IPC: B02C25/00
Filed: 2010-05-12
Abstract: A pulverizer 60 includes a spring assembly 10 that urges a grinding roller 72 of a journal assembly 68 onto a grinding surface 66 of a grinding table 64. The force applied is monitored by a load cell 32 located within spring assembly 10 that creates an electronic signal. A controller 83 receives the electronic signal and stores and/or displays it and alternatively acts to adjust the applied force to a desired value. Alternatively, adjustable forces or mechanical dampening may be applied to journal assembly 68 by controller 83. Alternatively, additional sensors may measure displacement of the journal assembly and rotation of the grinding table for other calculations.
Patent CA-2766574-A1 (CA)
Title: Methods and compositions for affecting the differentiation of clostridia in culture
Inventor: MATTSSON DONALD
IPC: C12P7/28
Filed: 2010-06-29
Abstract: The invention relates generally to methods and compositions for maintaining and manipulating microbial cultures of Gram-positive bacteria. Also provided are methods for identifying quorum sensing regulatory proteins and auto-inducing peptides in Gram-positive bacteria. Also provided are methods and compositions for affecting quorum sensing pathways of the genus Clostridium in culture including auto-inducing peptides to direct or maintain Clostridium cultures in a desired differentiated state. Differentiated states include extended serial propagation for the production of butanol or other fermentation products.
Patent CA-2767692-A1 (CA)
Inventor: CHEN FENG-JING
IPC: A61K9/107
Filed: 2010-07-01
Abstract: Disclosed is a pharmaceutical composition of a hepatitis C viral protease inhibitor which is suitable for oral administration via a liquid- or semi-solid-filled capsule and methods of using this composition for inhibiting the replication of the hepatitis C virus (HCV) and for the treatment of an HCV infection. The liquid- or semi-solid pharmaceutical composition of the present invention comprises a compound of formula I, or a pharmaceutically acceptable salt thereof, together with one or more pharmaceutically acceptable lipids and hydrophilic surfactants.
Patent CA-2769800-A1 (CA)
Inventor: BIRD ANDREW
IPC: C02F1/40
Filed: 2012-02-28
Abstract: A diffuser baffle for use in an in-line wastewater grease interceptor. The diffuser baffle lies within a grease collecting chamber between the inflow and outflow of a grease interceptor. The diffuser baffle has an open bottom which is sized and shaped respectively to fit into the grease collecting chamber. The diffuser baffle has an end operatively connected to the inflow opening to permit wastewater to flow into the body through the open bottom. The baffle has a downstream end which includes a deflector portion to deflect a wastewater stream in a direction generally into the grease collecting chamber. The body also includes a number of apertures to permit the deflected wastewater stream to pass through the baffle and into the grease collecting chamber, where FOG will separate before waste water exits the chamber through the outlet baffle.
Patent CA-2772291-A1 (CA)
Title: Stable sns-595 compositions and methods of preparation
Inventor: SUDHAKAR ANANTHA
IPC: C07D417/14
Filed: 2010-09-03
Abstract: Methods of preparing substantially pure SNS-595 substance are disclosed. Also provided are compositions comprising SNS-595 substance that are substantially pure and essentially free of visible particles.
Patent CA-2772447-A1 (CA)
Title: Steroidogenesis modified cells and methods for screening for endocrine disrupting chemicals
Inventor: ZHANG XIAOWEI
IPC: C12N15/00
Filed: 2010-09-16
Abstract: An isolated steroidogenesis modified cell comprising one or more steroid biosynthesis knock down nucleic acid operatively linked to a promoter, wherein the steroid biosynthesis knock down nucleic acid reduces the expression of a gene selected from the group CYP21A2, CYP11A1, CYP17A1, CYP19A1, 3-ßHSD1, 3-ßHSD2, 17-ßHSD1, StAR, HMGR, CYP11 B2, CYP11 B1, 5a-Reductase 2, SULT1 E1, CYP3A4 and UTG1A1, wherein the cell comprises reduced expression of one or more of said genes. The cells are useful for identifying endocrine disruptors. Accordingly, the disclosure includes in a further aspect a screening assay for identifying an endocrine disruptor comprising: a) contacting a cell described herein with a test substance; b) determining a level of at least one steroid or steroidogenic gene mRNA or enzyme activity;wherein a modulation in the level of the at least one steroid or steroidogenic gene mRNA or enzyme activity compared to a control is indicative that the test substance is an endocrine disruptor.
Patent CA-2775131-A1 (CA)
Title: End frame for display structure
Inventor: STUKENBERG JOSEPH R
IPC: A47B47/00
Filed: 2012-05-01
Abstract: An end frame assembly, for use with a display unit including a post having at least one aperture formed through each of two opposing surfaces of the post, comprises an end frame, a first stationary plate coupled to the end frame, a second stationary plate coupled to the end frame and spaced from and extending substantially coplanarly with respect to the first stationary plate, and a first slide plate disposed over the first stationary plate and including a first tab configured to fit within one aperture formed through one of the two opposing surfaces of the post. The first slide plate is selectively coupled with the first stationary plate via at least a first fastener, and the first fastener is selectively releasable to selectively allow linear movement of the first slide plate and selectively securable to hold the first slide plate in a substantially static.
Patent CA-2780997-A1 (CA)
Title: Dumpster for holding waste material
Inventor: FERRACCIOLI LUCA
IPC: B65F1/14
Filed: 2010-11-15
Abstract: A dumpster for holding waste material has a cup- shaped body (2), a lid (3) and one or more hooking means (4), which are suitable to connect the dumpster (1) to a waste collection device; the dumpster (1) has one or more openings (18) obtained in the body (2) or in the lid (3) and has one or more inserts (16), each of which is suitable to close a corresponding opening (18); each insert (16) comprises a plate (27) made of translucent material and is provided, in turn with a fixing system (19, 20, 23-25; 20, 23-25); the fixing system (19, 20, 23-25; 20, 23-25) having at least one damping means (24) suitable to attenuate vibration movements of the plate (27).